Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Coronavirus (COVID-19) Message Board

From a neighbor's analysis: The content of spik

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 716
(Total Views: 305)
Posted On: 10/05/2023 5:43:22 PM
Avatar
Posted By: someconcerns
Re: someconcerns #699
From a neighbor's analysis:

The content of spike protein mRNA in a vaccine dose has always been higher for Moderna than for Pfizer, although the difference is less now than originally:

Original vaccines: Moderna 100 vs. Pfizer 30 micrograms mRNA.

Booster shots: Moderna 50 vs. Pfizer 30 micrograms mRNA.

The 2023 vaccine (not a booster): Moderna 50 vs. Pfizer 30 micrograms mRNA. I was not able to find an article with this information, but I found it by downloading the package inserts of each vaccine and looking at the fine print to find the micrograms/dose.

The original Moderna vaccine was definitely more effective and effective longer than the Pfizer vaccine because of the 3.3x higher mRNA amount/dose. But with the 2023 vaccine the difference is probably minimal as the Moderna/Pfizer ratio is only 1.67.

Note that the articles cited in that link are from 2021 and likely (I did not check the actual primary sources) are based on the original formulations of vaccines. The original Moderna vaccine had twice as much mRNA as the current "updated 2023-2024"version has. So 2021 data is likely less useful for comparisons than newer data might be, if there is any, especially in people.

Secondly, T-cell immunity is as important as antibody-based immunity, if not more important, in protecting against disease. There seems to be much less T-cell data generated and/or available. Information response to vaccination that I have seen is generally based on antibody responses.

There seems to be limited new data available about the response in people to the newest vaccines.


(1)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us